Sepsis and pharmacogenomics: can the VAS(S)T majority of vasopressor treatment be individualized?*
- PMID: 25029134
- DOI: 10.1097/CCM.0000000000000372
Sepsis and pharmacogenomics: can the VAS(S)T majority of vasopressor treatment be individualized?*
Comment on
-
Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.Crit Care Med. 2014 Aug;42(8):1812-20. doi: 10.1097/CCM.0000000000000333. Crit Care Med. 2014. PMID: 24919159
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
